Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasms
×
Temozolomide
×
Clear all
Filters
3
NCT07195591
2026-03-04
BRIDGES
GT Medical Technologies, Inc.
Phase 3
Recruiting
766 enrolled
NCT03495921
2023-04-26
VITA
Gradalis, Inc.
Phase 3
Terminated
32 enrolled
13 charts
NCT01480479
2018-01-16
ACT IV
Celldex Therapeutics
Phase 3
Completed
745 enrolled